FDA seeks advice on whether to limit Covid-19 pill in pregnant people

.cms-textAlign-left{text-align:left;}.cms-textAlign-center{text-align:center;}.cms-textAlign-right{text-align:right;}.cms-magazineStyles-smallCaps{font-variant:small-caps;}

The Food and Drug Administration will ask independent advisers Tuesday whether to limit the use of a Covid-19 antiviral pill in pregnant people due to potential risks, according to agency documents posted Friday.

Merck and partner Ridgeback Biotherapeutics manufacture the drug, molnupiravir, which they say cuts in half the risk of hospitalization or death from Covid for patients with mild to moderate disease and has boosted hopes of finding a simple at-home treatment for the virus. Regulators are considering whether to

→ Continue reading at Politico

[ufc-fb-comments url="http://www.newyorkmetropolitan.com/news/fda-seeks-advice-on-whether-to-limit-covid-19-pill-in-pregnant-people"]

Latest Articles

Related Articles